Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - HEALTH DISCOVERY CORPFinancial_Report.xls
EX-10.1 - EXHIBIT 10.1 - HEALTH DISCOVERY CORPex10-1.htm
EX-32.1 - EXHIBIT 32.1 - HEALTH DISCOVERY CORPex32-1.htm
EX-31.1 - EXHIBIT 31.1 - HEALTH DISCOVERY CORPex31-1.htm
10-Q - FORM 10-Q - HEALTH DISCOVERY CORPt74989_10q.htm

EXHIBIT 10.2
 
Health Discovery Corporation
2 East Bryan Street, Suite 1500
Savannah, Georgia 31401
 
September 28, 2012
 
Stafford O’Kelly
Abbott Molecular VIA Email               
 
 
Stafford,
 
Health Discovery Corporation has received your notice that Abbott Molecular is not interested in moving forward with the Prostate Cancer License and Development Agreements.  It is our understanding that this results in a termination of these Agreements and we are in agreement with you and want to terminate the Agreements as well. Let this notice serve that the Agreements are now officially jointly terminated and that Abbott Molecular no longer has any rights granted to them under these Agreements.
 
Sincerely,
 
 
/s/ Stephen D. Barnhill, M.D.
 
Stephen D. Barnhill, M.D.
Chairman and Chief Executive Officer
Health Discovery Corporation
 
 
 

 
 
Health Discovery Corporation
2 East Bryan Street, Suite 1500
Savannah, Georgia 31401
 
September 28, 2012
 
Nicholas Conti
Quest Diagnostics VIA Email               
 
 
Nick,
 
Health Discovery Corporation has received your notice that Quest Diagnostics is not interested in moving forward with the Prostate Cancer License and Development Agreements and not making any additional payments required under such Agreements. It is our understanding that this results in a termination of these Agreements and we are in agreement with you and want to terminate the Agreements as well. Let this notice serve that the Agreements are now officially jointly terminated and that Quest Diagnostics no longer has any rights granted to them under these Agreements nor does Quest Diagnostics have any additional obligations under such Agreements.
 
Sincerely,
 
 
/s/ Stephen D. Barnhill, M.D.
 
Stephen D. Barnhill, M.D.
Chairman and Chief Executive Officer
Health Discovery Corporation
 
 
 

 
 
Health Discovery Corporation
2 East Bryan Street, Suite 1500
Savannah, Georgia 31401
 
September 28, 2012
 
Nicholas Conti
Quest Diagnostics VIA Email               
 
 
Nick,
 
Health Discovery Corporation and SmartPerMed have received your notice that Quest Diagnostics is not interested in moving forward with the Breast Cancer License and Development Agreements and not making any additional payments required under such Agreements. It is our understanding that this results in a termination of these Agreements and we are in agreement with you and want to terminate the Agreements as well. Let this notice serve that the Agreements are now officially jointly terminated and that Quest Diagnostics no longer has any rights granted to them under these Agreements nor does Quest Diagnostics have any additional obligations under such Agreements.
 
Sincerely,
 
 
/s/ Stephen D. Barnhill, M.D.
 
Stephen D. Barnhill, M.D.
Chairman and Chief Executive Officer
Health Discovery Corporation